Epileptic encephalitis: The role of the innate and adaptive immune system

Brain Pathology

Volumn 22, Issue 3, 2012, Pages 412-421

  Bauer, Jan ^a   Vezzani, Annamaria ^b   Bien, Christian G ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c EPILEPSY CENTER BETHEL   (Germany)

Author keywords

Antibodies; Brain; Cytotoxic T cells; Encephalitis; Interleukin 1; Microglial cells; Neuropathology; Seizures; Toll like receptors

Indexed keywords

GLUTAMATE DECARBOXYLASE 65; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ADAPTIVE IMMUNITY; CONFERENCE PAPER; ENCEPHALITIS; EPILEPTOGENESIS; HUMAN; INNATE IMMUNITY; NERVE DEGENERATION; NEUROPATHOLOGY; PARANEOPLASTIC NEUROPATHY; RASMUSSEN SYNDROME; SEIZURE;

ADAPTIVE IMMUNITY; ENCEPHALITIS; EPILEPSY; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE;

EID: 84859793566     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00580.x     Document Type: Conference Paper

References (114)

1. Albert ML, Austin LM, Darnell RB (2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 47:9-17. (Pubitemid 30033645)
2. Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764-1777. (Pubitemid 41373648)
3. Andermann F (1991) Chronic Encephalitis and Epilepsy. Rasmussen's Syndrome. Butterworth-Heinemann: Boston.
4. Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO (1996) Plasmapheresis in Rasmussen's encephalitis. Neurology 46:242-246. (Pubitemid 26156139)
5. Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG (2007) Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 62:67-80. (Pubitemid 47235282)
6. Bernal F, Graus F, Pifarre A, Saiz A, Benyahia B, Ribalta T (2002) Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol (Berl) 103:509-515. (Pubitemid 36075348)
7. Bien CG, Bauer J (2010) Rasmussen encephalitis. In: Inflammatory and Autoimmune Disorders of the Nervous System in Children. RC Dale, A Vincent (eds), pp. 207-226. Mac Keith Press: London.
8. Bien CJ, Bauer J, Deckwerth T, Wiendl H, Deckert M, Wiestler O et al (2002) Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 51:311-318. (Pubitemid 34206287)
9. Bien CG, Widman G, Urbach H, Sassen R, Kuczaty S, Wiestler OD et al (2002) The natural history of Rasmussen's encephalitis. Brain 125(Pt 8):1751-1759.
10. Bien CG, Gleissner U, Sassen R, Widman G, Urbach H, Elger CE (2004) An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology 62:2106-2109. (Pubitemid 38738233)
11. Bien CG, Elger CE, Leitner Y, Gomori M, Ran B, Urbach H et al (2007) Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures. Eur J Neurol 14:387-390. (Pubitemid 46481165)
12. Bien CG, Urbach H, Schramm J, Soeder BM, Becker AJ, Voltz R et al (2007) Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 69:1236-1244. (Pubitemid 47429024)
13. Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke M, Graus F et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain doi: 1093/brain/aws082.
14. Blumenthal DT, Salzman KL, Digre KB, Jensen RL, Dunson WA, Dalmau J (2006) Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology 67:146-149. (Pubitemid 44305481)
15. Boronat A, Sabater L, Saiz A, Dalmau J, Graus F (2011) GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 76:795-800.
16. Buckley C, Oger J, Clover L, Tüzün E, Carpenter K, Jackson M, Vincent A (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50:73-78.
17. Busbridge NJ, Dascombe MJ, Tilders FJ, van Oers JW, Linton EA, Rothwell NJ (1989) Central activation of thermogenesis and fever by interleukin-1 beta and interleukin-1 alpha involves different mechanisms. Biochem Biophys Res Commun 162:591-596. (Pubitemid 19200880)
18. Camdessanche JP, Streichenberger N, Cavillon G, Rogemond V, Jousserand G, Honnorat J et al (2011) Brain immunohistopathological study in a patient with anti-NMDAR encephalitis. Eur J Neurol 18:929-931.
19. Chan D, Henley SM, Rossor MN, Warrington EK (2007) Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels. Arch Neurol 64:404-410. (Pubitemid 46425696)
20. Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C et al (1999) Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122(Pt 1):27-39. (Pubitemid 29046270)
21. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36. (Pubitemid 46214241)
22. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091-1098.
23. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63-74.
24. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F et al (2000) Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 12:2623-2633. (Pubitemid 30497055)
25. Dunstan EJ, Winer JB (2006) Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. Age Ageing 35:536-537. (Pubitemid 44295648)
26. Eid T, Williamson A, Lee TS, Petroff OA, de Lanerolle NC (2008) Glutamate and astrocytes - key players in human mesial temporal lobe epilepsy? Epilepsia 49(Suppl. 2):42-52. (Pubitemid 351143765)
27. Eriksson C, Van Dam AM, Lucassen PJ, Bol JG, Winblad B, Schultzberg M (1999) Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 93:915-930. (Pubitemid 29341639)
28. Farrell MA, Droogan O, Secor DL, Poukens V, Quinn B, Vinters HV (1995) Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol (Berl) 89:313-321.
29. Geis C, Weishaupt A, Hallermann S, Grunewald B, Wessig C, Wultsch T et al (2010) Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 133:3166-3180.
30. Giometto B, Marchiori GC, Nicolao P, Scaravilli T, Lion A, Bardin PG, Tavolato B (1997) Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol 23:468-474. (Pubitemid 28019848)
31. Granata T (2003) Rasmussen's syndrome. Neurol Sci 24(Suppl. 4):S239-SS43.
32. Granata T, Fusco L, Gobbi G, Freri E, Ragona F, Broggi G et al (2003) Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology 61:1807-1810. (Pubitemid 38020838)
33. Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C (1990) Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 40:219-222. (Pubitemid 20099426)
34. Graus F, Saiz A, Lai M, Bruna J, Lopez F, Sabater L et al (2008) Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 71:930-936.
35. Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257:509-517.
36. Hauf M, Wiest R, Nirkko A, Strozzi S, Federspiel A (2009) Dissociation of epileptic and inflammatory activity in Rasmussen Encephalitis. Epilepsy Res 83:265-268.
37. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA (1996) Dementia and adult-onset unprovoked seizures. Neurology 46:727-730. (Pubitemid 26099639)
38. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C et al (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225-230. (Pubitemid 32163159)
39. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R et al (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866-5875.
40. Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M et al (2007) Anti-NMDA receptor encephalitis in Japan. Long-term outcome without tumor removal. Neurology 70:504-511.
41. Iizuka T, Yoshii S, Kan S, Hamada J, Dalmau J, Sakai F, Mochizuki H (2010) Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 257:1686-1691.
42. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133:2734-2748.
43. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS et al (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133(Pt 6):1655-1667.
44. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR et al (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892-900.
45. Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA, Aronica E (2010) Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51: 1763-1773.
46. Jean WC, Dalmau J, Ho A, Posner JB (1994) Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 44:140-147. (Pubitemid 24029445)
47. Kang TC, Kim DS, Kwak SE, Kim JE, Won MH, Kim DW et al (2006) Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy. Glia 54:258-271. (Pubitemid 44316231)
48. Khan NL, Jeffree MA, Good C, Macleod W, Al-Sarraj S (2009) Histopathology of VGKC antibody-associated limbic encephalitis. Neurology 72:1703-1705.
49. Korn-Lubetzki I, Bien CG, Bauer J, Gomori M, Wiendl H, Trajo L et al (2004) Rasmussen encephalitis with active inflammation and delayed seizures onset. Neurology 62:984-986. (Pubitemid 38435793)
50. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776-785.
51. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J et al (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67-76.
52. Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69:303-311.
53. Li Y, Uccelli A, Laxer KD, Jeong MC, Vinters HV, Tourtellotte WW et al (1997) Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol 158:1428-1437. (Pubitemid 127469970)
54. Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760-767.
55. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342. (Pubitemid 40516158)
56. Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470-478.
57. Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J (2010) Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies. J Neurol 258:27-33.
58. Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J (2007) Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 61:544-551. (Pubitemid 47068136)
59. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM et al (2010) Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16:413-419.
60. Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A (2011) Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurother 8:304-315.
61. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J (2011) Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 77:589-593.
62. Mata S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B et al (2008) Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 199:155-159.
63. Mazzi G, Roia DD, Cruciatti B, Mata S, Catapano R (2008) Plasma exchange for anti-GAD associated non paraneoplastic limbic encephalitis. Transfus Apher Sci 39:229-233.
64. Meinck HM, Thompson PD (2002) Stiff man syndrome and related conditions. Mov Disord 17:853-866.
65. Meinck HM, Faber L, Morgenthaler N, Seissler J, Maile S, Butler M et al (2001) Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J Neurol Neurosurg Psychiatry 71:100-103.
66. Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M (1990) Convulsants induce interleukin-1 beta messenger RNA in rat brain. Biochem Biophys Res Commun 171:832-837. (Pubitemid 20289459)
67. Minami M, Kuraishi Y, Satoh M (1991) Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun 176:593-598.
68. Nelson KB, Lynch JK (2004) Stroke in newborn infants. Lancet Neurol 3:150-158. (Pubitemid 38229949)
69. Nishiyori A, Minami M, Takami S, Satoh M (1997) Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. Brain Res Mol Brain Res 50:237-245. (Pubitemid 27488912)
70. Noebels J (2011) A perfect storm: converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia 52(Suppl. 1):39-46.
71. Oguni H, Olivier A, Andermann F, Comair J (1991) Anterior callosotomy in the treatment of medically intractable epilepsies: a study of 43 patients with a mean follow-up of 39 months. Ann Neurol 30:357-364.
72. Palmer CA, Geyer JD, Keating JM, Gilliam F, Kuzniecky RI, Morawetz RB, Bebin EM (1999) Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3. Epilepsia 40:242-247. (Pubitemid 29066312)
73. Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM (2004) The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 45:516-526. (Pubitemid 38581564)
74. Park DC, Murman DL, Perry KD, Bruch LA (2007) An autopsy case of limbic encephalitis with voltage-gated potassium channel antibodies. Eur J Neurol 14:e5-e6. (Pubitemid 47459748)
75. Piatt JH, Jr, Hwang PA, Armstrong DC, Becker LE, Hoffman HJ (1988) Chronic focal encephalitis (Rasmussen syndrome): six cases. Epilepsia 29:268-279.
76. Posner JB (1991) Paraneoplastic syndromes. Neurol Clin 9: 919-936.
77. Pozo-Rosich P, Clover L, Saiz A, Vincent A, Graus F (2003) Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 54:530-533. (Pubitemid 37176552)
78. Rasmussen T, Olszewski J, Lloyd-Smith D (1958) Focal seizures due to chronic localized encephalitis. Neurology 8:435-445.
79. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D et al (2006) The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24:128-143. (Pubitemid 44416213)
80. Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noe F et al (2006) Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 47:1160-1168. (Pubitemid 44086751)
81. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29:142-160. (Pubitemid 350180489)
82. Rivest S (2009) Regulation of innate immune responses in the brain. Nat Rev Immunol 9:429-439.
83. Robitaille Y (1991) Neuropathologic aspects of chronic encephalitis. In: Chronic Encephalitis and Epilepsy Rasmussen's Syndrome. F Andermann (ed.), pp. 79-110. Butterworth-Heinemann: Boston.
84. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B et al (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265:648-651.
85. Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F (1997) Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 49:1026-1030.
86. Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553-2563.
87. Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, Dornmair K, Wiendl H (2009) CD8+ T cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 132:1236-1246.
88. Solimena M, Folli F, Denis Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318:1012-1020. (Pubitemid 18095005)
89. Striano P, Perruolo G, Errichiello L, Formisano P, Beguinot F, Zara F, Striano S (2006) Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes. Ann Neurol 63:127-128.
90. Takei H, Wilfong A, Malphrus A, Yoshor D, Hunter JV, Armstrong DL, Bhattacharjee MB (2010) Dual pathology in Rasmussen's encephalitis: a study of seven cases and review of the literature. Neuropathology 30:381-391.
91. Tanaka K, Tanaka M, Inuzuka T, Nakano R, Tsuji S (1999) Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 163:159-162. (Pubitemid 29234239)
92. Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S (1998) Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 161:88-90. (Pubitemid 28559189)
93. Thomas JE, Reagan TJ, Klass DW(1977) Epilepsia partialis continua. A review of 32 cases. Arch Neurol 34:266-275. (Pubitemid 8096420)
94. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J et al (2005) An astrocytic basis of epilepsy. Nat Med 11:973-981. (Pubitemid 41294443)
95. Turner MR, Irani SR, Leite IM, Nithi K, Vincent A, Ansorge O (2011) Glycine & NMDA receptor antibodies in progressive encephalomyelitis with rigidity & myoclonus. Neurology 77: 414-415.
96. Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J (2009) Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol (Berl) 118:737-743.
97. Van Dam AM, Bauer J, Tilders FJ, Berkenbosch F (1995) Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 65:815-826.
98. Vernadakis A (1996) Glia-neuron intercommunications and synaptic plasticity. Prog Neurobiol 49:185-214.
99. Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, Dalmau J (1996) Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (Berl) 91:519-525. (Pubitemid 26133664)
100. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG (1999) Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19:5054-5065. (Pubitemid 29270140)
101. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A et al (2000) Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 97:11534-11539.
102. Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T et al (2002) Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43(Suppl. 5):30-35. (Pubitemid 34864203)
103. Vezzani A, Balosso S, Maroso M, Zardoni D, Noe F, Ravizza T (2010) ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs 11:43-50.
104. Vezzani A, French J, Bartfai T, Baram TZ (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7:31-40.
105. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127(Pt 3):701-712. (Pubitemid 38295483)
106. Vincent A, Bien CG, Irani SR, Waters P (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10:759-772.
107. Viviani B, Gardoni F, Marinovich M (2007) Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82:247-263.
108. Voltz R, Dalmau J, Posner JB, Rosenfeld MR (1998) T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 51:1146-1150. (Pubitemid 28473416)
109. Whitney KD, Andrews JM, McNamara JO (1999) Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology 53:699-708. (Pubitemid 29448288)
110. Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, Dichgans J et al (2001) GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 57:1511-1514. (Pubitemid 32995743)
111. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK (2010) An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry (in press).
112. Yang QW, Lu FL, Zhou Y, Wang L, Zhong Q, Lin S et al (2011) HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab 31:593-605.
113. Zhang Q, Tanaka K, Sun P, Nakata M, Yamamoto R, Sakimura K et al (2012) Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis 45:610-615.
114. Zurolo E, Iyer A, Maroso M, Carbonell C, Anink JJ, Ravizza T et al (2011) Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 134 (Pt 4):1015-1032.